Digital Laparoscopic Platform Leverages Augmented Intelligence and Machine Learning
|
By HospiMedica International staff writers Posted on 29 Jun 2022 |

Challenges in laparoscopic surgery can impact cost, utilization, effectiveness, and outcomes of the procedure. For instance, the inability of the surgeon to control vision can create efficiency and safety challenges. Quick movement or unsteady control of the camera can cause fogging, which requires a pause in the procedure for cleaning. Moreover, the limitations of traditional laparoscopy impact clinical intelligence, which is defined as point-of-care knowledge that allows a surgeon to make more informed decisions that may drive improved outcomes and procedural efficiency. Now, a first of its kind digital laparoscopic platform aims to eliminate the challenges and limitations of traditional laparoscopy by leveraging augmented intelligence to provide unmatched performance and patient outcomes through machine learning.
The Senhance Surgical System from Asensus Surgical, Inc. (Durham, NC, USA) is the first and only digital laparoscopic platform designed to support hospitals and surgeons by providing greater control in laparoscopy, reduce variability and increase OR efficiency. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, Senhance aims to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare.
Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical Unit (ISU). The ISU enables machine vision-driven tools to gather data related to anatomical structures and control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field and allows a surgeon to change the visualized field of view using the movement of their instruments.
Asensus intends to unlock clinical intelligence and capabilities to reduce surgical variability and the complications associated with it by adding machine vision, augmented intelligence, and deep learning capabilities that will be built upon the digital library of data collected from surgeries performed using Senhance. The insights gained from these cases will help deliver on the promise of consistently superior surgery regardless of a surgeon’s experience or skill level by guiding improved decision making, enriching collaboration, and enhancing predictability.
Related Links:
Asensus Surgical, Inc.
Latest Surgical Techniques News
- Neural Device Regrows Surrounding Skull After Brain Implantation
- Surgical Innovation Cuts Ovarian Cancer Risk by 80%
- New Imaging Combo Offers Hope for High-Risk Heart Patients
- New Classification System Brings Clarity to Brain Tumor Surgery Decisions
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
- NIR Light Enables Powering and Communicating with Implantable Medical Devices
- Simple Bypass Protocol Improves Outcomes in Chronic Cerebral Occlusion
Channels
Artificial Intelligence
view channelCritical Care
view channel
AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
Valvular heart disease affects more than half of people over 65, yet it often goes undiagnosed until symptoms become severe. In advanced stages, untreated cases can carry a mortality risk of up to 80%... Read more
Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
Glioblastoma is the most common and aggressive form of brain tumor, characterized by rapid growth, high invasiveness, and an extremely poor prognosis. Even with surgery followed by radiotherapy and chemotherapy,... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







